Shenzhen, China, 21 December 2023 – MGI, a company committed to building core tools and technology to lead life science, today announced the collaboration partnership with Indonesia’s National Research and Innovation Agency (BRIN) on co-building platforms and scientific research innovation. Leveraging advanced platform tools, MGI aims to empower marine genomics research, promoting the conservation and sustainable development of marine biodiversity.
Indonesia, located at the confluence of the Pacific and Indian Oceans, is one of the most biodiverse regions in the world. This partnership brings together the strengths of both organisations to develop shared platforms and apply innovative technologies to protect and study local genetic resources, supporting research and conservation efforts for marine biodiversity amid growing ecological challenges.
Amarula, Vice Chairman of Indonesia’s National Research and Innovation Agency, praised MGI for its breakthroughs in life sciences tool and platform innovation and welcomed closer collaboration with MGI across a range of research areas and platform development initiatives in Indonesia.
Duncan Yu, President of MGI, expressed his enthusiasm for the partnership with BRIN, highlighting Indonesia’s exceptional marine biodiversity. He noted that the collaboration will focus on in-depth cooperation in life sciences tools, technological empowerment and related areas to help strengthen Indonesia’s biodiversity research and conservation capabilities.
Representatives from BRIN and MGI
It is noteworthy that on 14 August 2022, Indonesia officially launched its first “National Genome Program”, with MGI as one of its designated sequencing platform partners. MGI provided a complete set of life science tools, including the DNBSEQ-T7RS high-throughput sequencer, MGISP-960RS high-throughput automated sample preparation system, MGISP-NE384RS fully automated nucleic acid extraction and purification instrument, and the ZTRON integrated data platform. These tools helped establish an efficient, fully automated high-throughput sequencing technology platform, contributing to the program’s goal of completing the whole-genome sequencing of 10,000 Indonesians within two years.
In recent years, MGI’s platforms and tools have actively supported researchers in various marine genomics projects, including studies on biological evolution, biodiversity and environmental protection, marine resource exploration, and marine genomics development, achieving breakthrough results.
As of 30 September 2023, MGI’s business spans over 100 countries and regions across six continents, serving a cumulative total of more than 2,600 users globally. Moving forward, MGI will continue to adhere to a global strategic layout, providing core tools in life sciences with leading technological capabilities to empower global health initiatives and contribute to building a “community with a shared future for humanity.”
